PharmaCE- Continuing Education


Rheumatology
Update on Abatacept Program Information
Exp: 8/31/10  Journal: The Annals  CEUs: 0.1  ACPE No.: 407-000-07-017-H01  Abstract   Test
Add To Cart   View Cart View Cart
Interleukin-1 in RA Program Information
Exp: 4/30/10  Journal: jPT  CEUs: 0.1  ACPE No.: 407-000-07-051-H01  Abstract   Test
Add To Cart   View Cart View Cart
Febuxostat: A Selective Xanthine Oxidase Inhibitor for the Treatment of Hyperuricemia and Gout Program Information
Exp: 12/31/09  Journal: The Annals  CEUs: 0.1  ACPE No.: 407-000-06-032-H01  Abstract   Test
Add To Cart   View Cart View Cart
Febuxostat: A Novel, Non-Purine Xanthine Oxidase Inhibitor Program Information
Exp: 12/31/09  Journal: jPT  CEUs: 0.1  ACPE No.: 407-000-06-057-H01  Abstract   Test
Add To Cart   View Cart View Cart
Abatacept: A Novel Agent for Rheumatoid Arthritis Program Information
Exp: 12/31/09  Journal: jPT  CEUs: 0.1  ACPE No.: 407-000-06-056-H01  Abstract   Test
Add To Cart   View Cart View Cart
Efalizumab for the Treatment of Moderate to Severe Plaque Psoriasis Program Information
Exp: 08/31/08  Journal: The Annals  CEUs: 0.1  ACPE No.: 407-000-05-026-H01  Abstract   Test
Add To Cart   View Cart View Cart
Use of Macrolides and Tetracyclines for Chronic Inflammatory Diseases Program Information
Exp: 01/31/08  Journal: The Annals  CEUs: 0.15  ACPE No.: 407-000-05-003-H01  Abstract   Test
Add To Cart   View Cart View Cart
PharmaCETM
is a service of HARVEY WHITNEY BOOKS COMPANY
8044 Montgomery Road, Suite 415, Cincinnati, OH 45236-2919
P.O. Box 42696, Cincinnati, OH 45242-0696 USA
Toll Free: 877/742-7631
Tel. 513/793-3555, FAX 513/793-3600
Office Hours: Monday - Friday 9-5 E.S.T.
Contact Us
All Rights Reserved. Copyright © 1998-